Insmed | INSM - Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
BioMarin Pharmaceutical USD 258.28M 63.92M 2026-03
Cytokinetics USD 104.9M 13.17M 2026-03
DBV Technologies USD 13.4M 8.14M 2026-03
Gilead Sciences USD 1.45B 326M 2026-03
Heron Therapeutics USD 23.74M 605K 2025-12
Insmed USD 247.26M 34.78M 2026-03
Novartis USD 3.14B 296M 2026-03
Regeneron Pharmaceuticals USD 647.7M 127.3M 2026-03
Sarepta Therapeutics USD 54.03M 51.35M 2026-03
Ultragenyx Pharmaceutical USD 88M 1000K 2026-03
Vertex Pharmaceuticals USD 493.7M 6.7M 2026-03